Abou-Alfa, G. K., Yen, Y., Harding, J. J., Whang-Peng, J., Shi, Y., Yuen, M. F., Li, X., Gu, S., Liu, C., Jeng, L., Yen, C. J., Pan, C. Q., Chen, S., Hsieh, J. C., Saif, M. W., Liu, S., Li, F., Lam, W., Chu, E., Cheng, Y. T. (2025). International phase II randomized placebo-controlled study investigating the combination of YIV-906 plus sorafenib (SORA) in HBV (+) patients (Pts) with advanced hepatocellular carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16244